Open AccessTrastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
Author(s) -
Guy Jérusalem,
Yeon Hee Park,
Toshinari Yamashita,
Sara A. Hurvitz,
Shanu Modi,
Fabrice André,
Ian E. Krop,
Xavier González,
Benoît You,
Cristina Saura,
SungBae Kim,
Cynthia R. Osborne,
Rashmi K. Murthy,
Lorenzo Gianni,
Toshimi Takano,
Yali Liu,
Jillian Cathcart,
Caleb Lee,
Christophe Perrin
Publication year - 2022
Publication title -
cancer discovery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.795
H-Index - 163
eISSN - 2159-8290
pISSN - 2159-8274
DOI - 10.1158/2159-8290.cd-22-0837
Subject(s) - trastuzumab , oncology , medicine , breast cancer , metastatic breast cancer , subgroup analysis , cancer , brain metastasis , metastasis , meta analysis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom